Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: zeta1961 who wrote (1591)	3/10/2006 8:30:58 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

INSM Has not been able to get off from its recent downtrend.<g> It needs to close its March 3 downgap. bigcharts.marketwatch.com And then close above 2.75 before it can think of trying to resume its previous uptrend.<g> bigcharts.marketwatch.com Bernard

To: zeta1961 who wrote (1591)	3/10/2006 8:37:50 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

If you are interested in oncolytic viruses take a look at ONCY <g> It has been trying to form a base at the 4.70 level bigcharts.marketwatch.com And with some good news it could get back to the $7 level later this year.<g> bigcharts.marketwatch.com It commented on its PI last Friday. "Early results of the study show that patients are experiencing local and systemic responses to the combination of REOLYSIN® and radiation treatment," said Dr. Matt Coffey, Oncolytics' Chief Scientific Officer. "We are pleased with these initial indications of activity, and look forward to providing an update of interim study results at the AACR annual meeting." biz.yahoo.com Bernard